HLB Co., Ltd.
028300
Kedudukan dalam Saham
#4121
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Harga Saham
$29.53
Modal Pasaran
$3.93B
Perubahan (1 hari)
-0.58%
Perubahan (1 tahun)
-7.70%
Negara
KR
Perdagangan HLB Co., Ltd. (028300)
Kategori
Healthcare
Pendapatan untuk HLB Co., Ltd. (028300)
Pendapatan pada Jun 2026 TTM: $-160.32M
Menurut laporan kewangan terkini HLB Co., Ltd., pendapatan semasa syarikat ialah $-160.32M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $-164.38M, penurunan berbanding pendapatan pada tahun 2022 yang berjumlah $-62.61M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi HLB Co., Ltd. dari 2012 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $-160.32M | 115.74% |
| 2024 | $-74.31M | -54.79% |
| 2023 | $-164.38M | 162.55% |
| 2022 | $-62.61M | -27.09% |
| 2021 | $-85.87M | 12.36% |
| 2020 | $-76.43M | 43.17% |
| 2019 | $-53.38M | -540.23% |
| 2018 | $12.13M | -138.75% |
| 2017 | $-31.29M | 69.49% |
| 2016 | $-18.46M | -310.93% |
| 2015 | $8.75M | -632.68% |
| 2014 | $-1.64M | -80.80% |
| 2013 | $-8.56M | 40.17% |
| 2012 | $-6.11M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $5.27B | -3,390.24% |
US
|
|
| $-3.09B | 1,825.53% |
US
|
|
| $-4.02B | 2,405.12% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -1,316.72% |
NL
|
